View in EDS

917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study.

Saved in:
Bibliographic Details
Title: 917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study.
Authors: Patel, M.R.1 (AUTHOR), Doi, T.2 (AUTHOR), Yamamoto, N.3 (AUTHOR), Garrido-Laguna, I.4 (AUTHOR), Nishioka, S.5 (AUTHOR), Wu, S.6 (AUTHOR), Ostheimer, C.7 (AUTHOR), Nakajima, K.7 (AUTHOR), Carneiro, B.A.8 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS598-S598. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.1486